Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001604457-26-000005

CEO gave up 18,611 shares (to pay taxes)

  • CEO acquired 63,475 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Walker Neal · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-03 Exercise or conversion : show line 1 in the form +63,475 1,562,497 D
2026-02-03 Shares withheld for taxes : show line 2 in the form −18,611 $3.47 $64,580 1,543,886 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-03 Exercise or conversion : show line 3 in the form Restricted Stock Units −63,475 190,425 D
Loading xslF345X05/form4-02052026_090254.xml…